维普期刊资源整合服务平台（V6.5）

87篇 您的检索式：作者名="Levitzki A"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Tyrosine kinase inhibition:an approach to drug development显示文摘	Levitzki A Gazit A	1995	Science1995，267，：	1
2	Inhibition of glioma growth by tumor-spe- cific activation of double-stranded rna-dependent protein kinase pkr显示文摘	Shir A Levitzki A	2002	Nat Biotechnol2002，20，9：	1
3	Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone 显示文摘	Burdelya L Catlett-Falcone R Levitzki A	2002	Mol Cancer Ther2002，1，：	1
4	Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR显示文摘	SHIR A LEVITZKI A	2002	Nat Biotechnol2002，20，9：	1
5	Tyrosine kinase inhibitors: views of selectivity,sensitivity, and clinical performance显示文摘	Levitzki A	2013	Annu Rev PharmacolToxicol2013，53，：	1
6	Tyrosine kinase inhibitor: views of selectivity sensitivity, and clinical performance显示文摘	Levitzki A	2013	Annu Rev Pharmacol Toxicol2013，53，：	1
7	Substrate competitive inhibitors of IGF-1 receptor kinase显示文摘	Blum G Gazit A Levitzki A	2000	Biochemistry2000，39，15：	1
8	Inhibition of pp60c-Src reduces Bcl-xL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors 显示文摘	Karni R Jove R Levitzki A	1999	Oncogene1999，18，33：	1
9	PDGF receptor kinase inhibitors for the treatment of PDGF driven diseases显示文摘	Levitzki A	2004	Cytokine Growth Factor Rev2004，15，：	1
10	Protein tyrosine kinase inhibitors as therapeutic agents显示文摘	Levitzki A	1998	Top Curr Chem1998，211，1：	1
11	Tyrosine kinase inhibitors:views of selectivity, sen- sitivity, and clinical performance 显示文摘	LEVITZKI A	2013	Annu Rev Pharmacol Toxi- col2013，53，：	1
12	Cisplatin induces PKB/Akt activation and p38MAPK phosphorylation of EGF receptor显示文摘	Winograd Katz S E Levitzki A	2006	Oncogene2006，25，：	1
13	Inhibition of glioma growth by tumor specific activation of double-stranded RNA-dependent protein kinase PKR显示文摘	Shir A Levitzki A	2002	Nat Biotechnol2002，20，9：	1
14	Targeted cancer immunotherapy显示文摘	Zigler M Shir A Levitzki A		0，，04：	1
15	Tyrosine kinases as targets for cancer therapy显示文摘	Levitzki A	2002	Eur J Cancer2002，385，：	1
16	Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites显示文摘	Lopez-Talavera JC Levitzki A Martinez A	1997	J Clin Invest1997，100，3：	1
17	Tyrosine kinase inhibition:An approach to drug development显示文摘	Levitzki A Gazit A	1995	Science1995，267，：	1
18	Tumor specific activation of PKR as a non-toxic modality of cancer treatment显示文摘	Shir A Friedrich I Levitzki A	2003	Semin Cancer Biol2003，13，4：	1
19	ROS,stress-activated kinases and stress signaling in cancer显示文摘	Benhar M Engelberg D Levitzki A		0，，5：	1
20	Tyrosine kinase inhibition:an approach to drug development显示文摘	Levitzki A Gazit A	1995	Science1995，267，5205：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示